银屑病关节炎妊娠期间及产后的疾病活动性:一项前瞻性多中心研究
该研究纳入挪威全国登记中103例银屑病关节炎女性的108次妊娠,前瞻性在妊娠前、妊娠期间及产后7个时间点评估疾病活动性。约75%的女性在妊娠期间及产后处于缓解或低疾病活动度,疾病活动性在妊娠期下降、产后6个月内升高,产后6个月显著高于产后6周。妊娠期使用TNFi者疾病活动性显著低于未使用者。
要点
- 约75%的银屑病关节炎女性在妊娠期间及产后处于缓解或低疾病活动度。
- 疾病活动性在妊娠期下降,产后6个月内升高,产后6个月显著高于产后6周。
- 妊娠期使用TNFi者疾病活动性显著低于未使用者。
核心结论
- 银屑病关节炎女性疾病活动性在产后6个月最高,但从计划妊娠至产后1年总体低且稳定。
- 妊娠期使用TNFi的女性疾病活动性显著更低。
研究设计与样本
- 前瞻性多中心研究,纳入挪威全国登记中103例银屑病关节炎女性的108次妊娠。
- 在妊娠前、妊娠期间及产后共7个时间点前瞻性评估疾病活动性,采用基于C反应蛋白的28关节疾病活动度评分(DAS28-CRP)和Bath强直性脊柱炎疾病活动指数(BASDAI)。
- 各时间点评分采用线性混合模型分析,并以「妊娠期使用肿瘤坏死因子抑制剂(TNFi)」为协变量进行额外分析。
- 采用相同统计方法研究自我报告的身体功能、疼痛和心理健康。
主要发现
- 根据DAS28-CRP评分,约75%的女性在妊娠期间及产后处于缓解或低疾病活动度。
- 疾病活动性总体稳定,但妊娠期下降、产后6个月内升高。
- 产后6个月DAS28-CRP平均评分2.71 vs 产后6周2.45(P=0.016),产后6个月显著更高。
- 妊娠期使用TNFi者产后6个月DAS28-CRP平均评分2.22 vs 未使用者2.72(P=0.043),使用TNFi者显著更低。
- BASDAI评分在妊娠期低且稳定,产后6个月平均评分3.69 vs 产后6周2.95(P=0.013),产后6个月显著更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study disease activity in women with peripheral psoriatic arthritis (PsA) during and after pregnancy. Previous knowledge on this topic is sparse. METHODS: The study included 108 pregnancies in 103 women with PsA from a Norwegian nationwide register. Disease activity was assessed prospectively at 7 time points before, throughout, and after pregnancy with the 3-variable Disease Activity Score in 28 joints (DAS28) using C-reactive protein levels and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Scores assessed at each time point were analyzed in a linear mixed model. We did additional analyses with "tumor necrosis factor inhibitor (TNFi) in pregnancy" as a covariate. The same statistical method was used to study self-reported physical function, pain, and mental health. RESULTS: Approximately 75% of the women were in remission or had low disease activity during and after pregnancy according to the DAS28-CRP score. Although disease activity was altogether stable, we found that it decreased in pregnancy and increased within 6 months postpartum. Disease activity at 6 months postpartum was significantly higher than at 6 weeks postpartum (mean DAS28-CRP score 2.71 versus 2.45; P = 0.016). Women using TNFi in pregnancy had significantly lower disease activity than women not using TNFi (mean DAS28-CRP score at 6 months postpartum 2.22 versus 2.72; P = 0.043). BASDAI scores were also low and stable during pregnancy but significantly higher at 6 months postpartum than at 6 weeks postpartum (mean BASDAI score 3.69 versus 2.95; P = 0.013). CONCLUSION: Studying women with PsA, we found that disease activity was highest at 6 months postpartum but altogether low and stable in the period from planning pregnancy to 1 year after delivery. Women using TNFi in pregnancy had significantly lower disease activity.
引用
- Ursin K, Lydersen S, Skomsvoll JF, et al. Psoriatic Arthritis Disease Activity During and After Pregnancy: A Prospective Multicenter Study. Arthritis Care Res (Hoboken). 2019. PMID: 30192071. doi:10.1002/acr.23747
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。